Collegium Announces $50 Million Accelerated Share Repurchase Program
Collegium Pharmaceutical entered into a $50 million Accelerated Share Repurchase agreement with Jefferies LLC, executing under its existing $150 million authorization. The transaction involves an initial delivery of approximately 1.56 million shares based on the August 12 closing price of $25.70, with final settlement expected in the fourth quarter of 2026.
Key figures
- Asr value usd
- 50000000
- Reference price
- 25.7
- Shares outstanding
- 32.5 million
- Remaining authorization
- 100000000
- Initial shares delivered
- 1556420
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.